US Markets

DuPont considers sale of nutrition and biosciences unit - Bloomberg

Credit: REUTERS/BRENDAN MCDERMID

Industrial materials maker DuPont is considering a sale of its nutrition and biosciences unit, Bloomberg reported on Tuesday, citing people familiar with the matter.

Adds details from Bloomberg report

Aug 6 (Reuters) - Industrial materials maker DuPont DD.N is considering a sale of its nutrition and biosciences unit, Bloomberg reported on Tuesday, citing people familiar with the matter.

The unit, which supplies everything from soy-based food ingredients to tablet binders, could be worth at least $20 billion as a standalone entity, Bloomberg said.

DuPont declined to comment on the unit's divestiture.

The Wilmington, Delaware-based company said in February that its overall goal was to divest about 10% of its portfolio.

DuPont was a part of DowDupont until a split earlier this year.

The nutrition and biosciences unit, DuPont's biggest revenue generator in 2018 on a pro-forma basis, was hit by lower sales of food, beverage and pharma solutions in the latest reported quarter, and brought in 4% lower sales than a year earlier.

(Reporting by Debroop Roy and Manojna Maddipatla in Bengaluru; Editing by Shinjini Ganguli)

((Debroop.Roy@thomsonreuters.com; within U.S. +1 646 223 8780, outside U.S. +91 80 6749 1690; Reuters Messaging: debroop.roy.thomsonreuters.com@reuters.net))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Reuters

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

Learn More